GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Biogena Group Invest AG (WBO:BIO) » Definitions » EPS without NRI

Biogena Group Invest AG (WBO:BIO) EPS without NRI : €0.04 (TTM As of Jan. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Biogena Group Invest AG EPS without NRI?

Biogena Group Invest AG's earnings per share without non-recurring items for the six months ended in Jan. 2024 was €0.04. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Jan. 2024 was €0.04.

During the past 12 months, Biogena Group Invest AG's average earnings per share (NRI) Growth Rate was -42.70% per year. During the past 3 years, the average earnings per share (NRI) Growth Rate was -9.50% per year. During the past 10 years, the average earnings per share (NRI) Growth Rate was 0.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for Biogena Group Invest AG's EPS without NRI or its related term are showing as below:

WBO:BIO' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -9.5   Med: -9.5   Max: -9.5
Current: -9.5

During the past 4 years, Biogena Group Invest AG's highest 3-Year average Earnings Per Share (NRI) Growth Rate was -9.50% per year. The lowest was -9.50% per year. And the median was -9.50% per year.

WBO:BIO's 3-Year EPS without NRI Growth Rate is ranked worse than
71.08% of 1428 companies
in the Consumer Packaged Goods industry
Industry Median: 7.2 vs WBO:BIO: -9.50

Biogena Group Invest AG's EPS (Diluted) for the six months ended in Jan. 2024 was €0.04. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Jan. 2024 was €0.04.

Biogena Group Invest AG's EPS (Basic) for the six months ended in Jan. 2024 was €0.04. Its EPS (Basic) for the trailing twelve months (TTM) ended in Jan. 2024 was €0.04.


Biogena Group Invest AG EPS without NRI Historical Data

The historical data trend for Biogena Group Invest AG's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biogena Group Invest AG EPS without NRI Chart

Biogena Group Invest AG Annual Data
Trend Jan21 Jan22 Jan23 Jan24
EPS without NRI
0.06 0.18 0.08 0.04

Biogena Group Invest AG Semi-Annual Data
Jan21 Jan22 Jan23 Jan24
EPS without NRI 0.06 0.18 0.08 0.04

Competitive Comparison of Biogena Group Invest AG's EPS without NRI

For the Packaged Foods subindustry, Biogena Group Invest AG's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biogena Group Invest AG's PE Ratio without NRI Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Biogena Group Invest AG's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Biogena Group Invest AG's PE Ratio without NRI falls into.



Biogena Group Invest AG EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. EPS without NRI for the trailing twelve months (TTM) ended in Jan. 2024 was €0.04

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Biogena Group Invest AG  (WBO:BIO) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Biogena Group Invest AG EPS without NRI Related Terms

Thank you for viewing the detailed overview of Biogena Group Invest AG's EPS without NRI provided by GuruFocus.com. Please click on the following links to see related term pages.


Biogena Group Invest AG (WBO:BIO) Business Description

Traded in Other Exchanges
N/A
Address
Strubergasse 24, Salzburg, AUT, 5020
Biogena Group Invest AG is a holding company. It is engaged in the development and distribution of products and services in the field of health and nutrition. In particular, the focus is on iron, mineral and osteoporosis product innovations and new integrated solutions in the area of workplace health promotion. Its products include vitamin, mineral, enzymes, medicinal mushrooms, among others.